Private Advisor Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Private Advisor Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,509	Closed	-$23K	–	2184
2022 Q2	$23K	Sell	11,509 -3,183	-22%	-$5.5K	﹤0.01%	2071
2022 Q1	$34K	Sell	14,692 -9,363	-39%	-$29.2K	﹤0.01%	2053
2021 Q4	$112K	Sell	24,055 -12,745	-35%	-$79.1K	﹤0.01%	2007
2021 Q3	$281K	Sell	36,800 -1,025	-3%	-$8.69K	﹤0.01%	1733
2021 Q2	$367K	Buy	37,825 +9,668	+34%	+$77K	﹤0.01%	1543
2021 Q1	$233K	Buy	+28,157	New	+$297K	﹤0.01%	1669
2020 Q4	–	Sell	-10,432	Closed	-$116K	–	1840
2020 Q3	$116K	Buy	10,432 +7,214	+224%	+$66K	﹤0.01%	1481
2020 Q2	$20K	Buy	+3,218	New	+$12.3K	﹤0.01%	2596

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Private Advisor Group's SRNE Position: Q3 2022 in Review

Private Advisor Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q3 2022, closing a stake of 11,509 shares — an estimated $23K sold.

Private Advisor Group first reported a position in SRNE in Q2 2020 and held it in 8 quarters. The position peaked at $367K in Q2 2021. 233 funds tracked by Wall St. Rank hold SRNE as of Q3 2022.

Private Advisor Group reported no remaining Sorrento Therapeutics, Inc. position as of Q3 2022 after selling out during the quarter.
Private Advisor Group sold 11,509 Sorrento Therapeutics, Inc. shares in Q3 2022, an estimated $23K.
Private Advisor Group first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 8 quarters.
Private Advisor Group's Sorrento Therapeutics, Inc. position peaked at $367K in Q2 2021.
233 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q3 2022.

Based on Private Advisor Group's 13F filing for Q3 2022, filed 14 Oct 2022.